Multi-MeMo (“Shorter- and longer-term mechanisms of multimodal interventions to prevent dementia”) is a European funded project that focuses on brain health in older people, overall, and tailored, multidomain interventions (i.e., targeting multiple risk factors simultaneously) for the risk-reduction of cognitive impairment and dementia, in particular. In addition to written contributions from two members, three other members of the Multi-MeMo Advisory Board (AB) gathered, on 3 June, for an online meeting. The Advisory Board comprises members of the public, both with and without cognitive impairment, who contribute valuable perspectives to the project’s research activities.
The meeting was facilitated by Sarah Campill (Alzheimer Europe), who was joined by Cindy Birck (Alzheimer Europe), Marissa Zwan (Amsterdam UMC), Mariagnese Barbera (University of Eastern Finland), Laura Forcano, Natalia Soldevila Domenech and Rafael de la Torre (Hospital del Mar Research Institute). The main topic of discussion was the communication of clinical trial results, particularly trials involving multimodal lifestyle interventions. Advisory Board members provided insightful feedback to help researchers better understand how to communicate research findings in ways that are relevant, engaging and easy to remember for different audiences. Their contributions highlighted the importance of clear, accessible and meaningful communication when sharing scientific results with the public.
The Multi-MeMo consortium would like to thank all Advisory Board members for their time, expertise and commitment.
